Home › Trial NCT04631835
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
- Trial IDNCT04631835
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorJiangsu Hansoh Pharmaceutical Co., Ltd.
- Enrollment54
- Start date2020-09-08
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.